| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_066828a4b6f7a816447cb8ba1bcbb40e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-96 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
1995-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2513244ade07dd7ae2b5b4e3fd0093e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a5488db82100ba3842ef760728ca52e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62b16e6331ed34b7446c45e845f0ca72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f42786110bef013cd5f25c0821ec6f76 |
| publicationDate |
1996-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0840928-A |
| titleOfInvention |
Stable composition for the treatment of blood coagulation disorders containing active procoagulants |
| abstract |
(57) [Summary] [Object] To provide a stable composition for treating a blood coagulation disorder and a method for producing the composition. A stable composition for preventing or treating a blood coagulation disorder, which comprises an active coagulation promoting substance which is bound to and / or on a lipid vesicle and is suitable for intravenous administration, and a method for producing the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005525424-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3868413-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009532371-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018505698-A |
| priorityDate |
1994-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |